The Effects of Short-Chain Fatty Acids in Psychosocial Stress-Induced Impairment on Core Executive Functions
NCT06286943 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2024-06-27
Summary
The aim of the present trial is to examine core executive functions (EFs) as a functional outcome of attenuating the cortisol response to acute laboratory stress through colonic delivery of an Short Chain Fatty Acids (SCFAs) mix (acetate, propionate, butyrate).
A triple-blind randomized placebo-controlled parallel group trial will be conducted to compare the effects of SCFAs vs. placebo on core EFs (working memory \[WM\], cognitive flexibility \[CF\], response inhibition \[RI\]) under stress vs. no-stress conditions, after one week of SCFA vs. placebo treatment.
First, the effects of SCFAs on stress-induced changes in core executive functions, with WM as the primary outcome, and CF and RI as secondary outcomes will be tested. Second, interindividual differences in microbiota composition (particularly abundance of SCFA-producers), saliva cortisol and serum SCFA levels will be explored to assess whether they are associated with interindividual differences in core EFs at baseline or following acute stress.
Each participant will undergo 2 study visits: one will involve a stress condition and the other will involve a no-stress condition. Each study visit is preceded by a 1-week intervention or placebo period and separated by a 3-4 week washout period. To induce stress, participants will perform the Maastricht Acute Stress Task (MAST) or sham MAST as the control condition. To assess EF performance, three cognitive tasks will be performed 15 minutes after task offset: n-back task for WM; Stop Signal Task for RI; and Wisconsin Card Sorting Test for CF. Saliva samples will be collected before, during and after the (sham) MAST to assess the cortisol response. Blood samples will be collected throughout all study visits to quantify serum SCFAs, inflammatory markers and ACTH. Additionally, cardiovascular variables will be measured, and self-report questionnaires will be completed to evaluate autonomic response to the condition and subjective stress responses, respectively
Conditions
- Executive Function
Interventions
- DIETARY_SUPPLEMENT
-
Short Chain Fatty Acids (SCFAs).
Colon-delivery capsules of SCFAs.
- DIETARY_SUPPLEMENT
-
Placebo
Microcrystaline cellulose placebo capsules.
- OTHER
-
Maastricht Acute Stress Task
The Maastricht Acute Stress Task. This 15-minute stress-inducing task consists of a 5-minute preparation phase where instructions about the upcoming tasks are given, followed by a 10-minute acute stress phase where the hand immersion trial (HIT) in ice-cold water and mental arithmetic (MA) task is given interchangeably.
- OTHER
-
No-stress control task
The placebo version of the MAST follows the same structure of the MAST with none of the stress elements. It uses lukewarm water and simple arithmetic's.
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-07-31
- Primary Completion
- 2025-09-30
- Completion
- 2025-11-30
More Related Trials
-
Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe
NCT02597439 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of a Nutritional Supplement on Mental Wellness in Adults
NCT06058364 ·Status: COMPLETED ·Phase: NA
-
Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder
NCT05573672 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Omega-3 Fatty Acids in Maintaining Optimal Mental Health in Elderly People
NCT00124852 ·Status: COMPLETED ·Phase: NA
-
The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years
NCT05177978 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment
NCT06951932 ·Status: RECRUITING ·Phase: NA
-
Fatty Acids and Executive Function Development in 7-12 Year Olds
NCT02199808 ·Status: COMPLETED
-
Effect of Intragastric Administration of Fatty Acids on Generalized Reward Sensitivity
NCT02984150 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Phospholipid Drink on Cognitive Performance Under Acute Stress
NCT01879813 ·Status: COMPLETED ·Phase: NA
-
Effect of Fish Oil on Athlete's Executive Function
NCT04570995 ·Status: TERMINATED ·Phase: NA
-
Polyunsaturated Fatty Acids (PUFA) Status and Cognitive Function in Healthy Young Adults
NCT01075958 ·Status: COMPLETED
-
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
NCT02908932 ·Status: COMPLETED ·Phase: NA
-
The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood
NCT02763514 ·Status: COMPLETED ·Phase: NA
-
Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age
NCT00351624 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Omega-3 Phospholipids on Perceptual-cognitive Training
NCT01856829 ·Status: COMPLETED ·Phase: NA
-
Whole Coffee Fruit Concentrate Pilot Study 1
NCT01965795 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids in Adolescent Depression
NCT00312897 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 Fatty Acids and Subconcussive Head Impacts
NCT06736925 ·Status: RECRUITING ·Phase: NA
-
Effects of a High EPA Multinutrient Supplement on Negative Affect in Young Adults.
NCT04844034 ·Status: UNKNOWN ·Phase: NA
-
Docosahexaenoic Acid (DHA) Supplementation in High Risk Pregnancies
NCT04069195 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Omega-3/Omega-6 Fatty Acids in Pre-school Children at Risk for ADHD
NCT01795040 ·Status: UNKNOWN ·Phase: NA
-
Reducing Aggression Among People With an Intellectual Disability
NCT03212092 ·Status: COMPLETED ·Phase: NA
-
Essential Fatty Acid Nutrition For 1-2 Yr-Olds
NCT01263912 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels
NCT03781557 ·Status: UNKNOWN ·Phase: PHASE4
-
NAPLS Omega-3 Fatty Acid Versus Placebo Study
NCT01429454 ·Status: COMPLETED ·Phase: PHASE1